Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM5A | P29375 | 2/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9705223 | 0.95 | DNM1 (0.46) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL20959832 | 0.93 | HTT (0.39) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL19637028 | 0.91 | MEN1 (0.50) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL17147981 | 0.90 | MEN1 (0.57) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL15279332 | 0.89 | MEN1 (0.60) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL18211263 | 0.89 | DNM1 (0.46) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL9705221 | 0.88 | DNM1 (0.39) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL20959814 | 0.87 | MEN1 (0.53) | THRBMEN1HTTKMT2AMAPT | |
| SCHEMBL28972955 | 0.87 | DNM1 (0.56) | DNM1THRBMEN1HTTKMT2A | |
| SCHEMBL7695726 | 0.86 | DNM1 (0.42) | DNM1THRBMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | DNM1 1194/4885THRB 2394/4885MEN1 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.